|
Delayed
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | -99.33% |
| 06/08 | Morphic Medical Announces Board Appointments, Effective August 6, 2026 | CI |
| 03/08 | Morphic Medical Inc. Provides Update On Reset System Clinical And Commercial Progress | CI |
| Market Cap | 4L 4L 4L 3L 6L 4.26Cr 6L 43.9L 17.19L 2.17Cr 16.53L 16.18L 6.95Cr | P/E 2019 |
-1.12x | P/E 2020 | -0.03x |
|---|---|---|---|---|---|
| Enterprise Value | 32.79L 29.25L 27.26L 24.8L 46.64L 32Cr 47.13L 3.27Cr 1.28Cr 16Cr 1.23Cr 1.2Cr 52Cr | EV / Sales 2019 |
-
| EV / Sales 2020 | - |
| Free-Float |
-
| Yield 2019 * |
-
| Yield 2020 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Mike Gutteridge
CEO | Chief Executive Officer | - | 05/08/2025 |
Jane Wright
DFI | Director of Finance/CFO | 57 | 01/08/2025 |
| Chief Tech/Sci/R&D Officer | - | 01/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Ginger Glaser
BRD | Director/Board Member | - | 20/10/2020 |
Alex Escalona
BRD | Director/Board Member | - | - |
John R. Barr
BRD | Director/Board Member | 69 | 01/10/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 28/01/21 | Free | Chairman | 13,84,483 | 0.4875% | ||
| 28/01/21 | Free | Chief Executive Officer | 1,10,75,869 | 3.8998% |
| 2019 | 2020 | |
|---|---|---|
| Net sales | - | - |
| Net income | -1.73Cr -1.55Cr -1.44Cr -1.31Cr -2.47Cr -167.7Cr -2.49Cr -17Cr -6.77Cr -85Cr -6.51Cr -6.37Cr -273.5Cr | -1.11Cr -99.33L -92.56L -84.21L -1.58Cr -107.74Cr -1.6Cr -11Cr -4.35Cr -55Cr -4.18Cr -4.09Cr -175.72Cr |
| Net Debt | 28.87L 25.75L 24L 21.83L 41.06L 28Cr 41.49L 2.88Cr 1.13Cr 14Cr 1.08Cr 1.06Cr 46Cr | 28.39L 25.32L 23.6L 21.47L 40.38L 27Cr 40.8L 2.83Cr 1.11Cr 14Cr 1.07Cr 1.04Cr 45Cr |
Employees
-
Sector
-
- Stock Market
- Stocks
- GIDYL Stock
Select your edition
All financial news and data tailored to specific country editions
















